Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65451 - 65475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	NOS3	4846	upregulated	resveratrol results in increased expression of NOS3 mRNA	7q36.1	A21076 A23987 A23990 A22962 A23964 A22523 A21627 A23988 A23991 A23856
Resveratrol	Investigational	NOTCH1	4851	downregulated	resveratrol results in decreased expression of NOTCH1 mRNA	9q34.3	A23913
Resveratrol	Investigational	NOTCH1	4851	upregulated	resveratrol results in increased expression of NOTCH1 mRNA	9q34.3	A23943
Resveratrol	Investigational	NOTCH2	4853	downregulated	resveratrol results in decreased expression of NOTCH2 mRNA	1p12	A23913 A23870
Resveratrol	Investigational	NOTCH2	4853	upregulated	resveratrol results in increased expression of NOTCH2 mRNA	1p12	A23860
Resveratrol	Investigational	NOX4	50507	downregulated	resveratrol results in decreased expression of NOX4 mRNA	11q14.3	A23949
Resveratrol	Investigational	NPAS2	4862	upregulated	resveratrol results in increased expression of NPAS2 mRNA	2q11.2	A22498 A23847
Resveratrol	Investigational	NPC1	4864	upregulated	resveratrol results in increased expression of NPC1 mRNA	18q11.2	A22289
Resveratrol	Investigational	NPC2	10577	upregulated	resveratrol results in increased expression of NPC2 mRNA	14q24.3	A23908
Resveratrol	Investigational	NPPA	4878	downregulated	resveratrol results in decreased expression of NPPA mRNA	1p36.22	A23893
Resveratrol	Investigational	NPPC	4880	upregulated	resveratrol results in increased expression of NPPC mRNA	2q37.1	A23964
Resveratrol	Investigational	NQO1	1728	downregulated	resveratrol analog results in decreased expression of NQO1 mRNA	16q22.1	A21908
Resveratrol	Investigational	NQO1	1728	upregulated	[resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA	16q22.1	A23946
Resveratrol	Investigational	NQO1	1728	upregulated	resveratrol results in increased expression of NQO1 mRNA	16q22.1	A23992 A23993 A23947 A23946 A23956
Resveratrol	Investigational	NR0B2	8431	upregulated	resveratrol results in increased expression of NR0B2 mRNA	1p36.11	A23994
Resveratrol	Investigational	NR1H3	10062	upregulated	resveratrol results in increased expression of NR1H3 mRNA	11p11.2	A23842
Resveratrol	Investigational	NR3C1	2908	downregulated	resveratrol results in decreased expression of NR3C1 mRNA	5q31.3	A23858
Resveratrol	Investigational	NRF1	4899	upregulated	resveratrol results in increased expression of NRF1 mRNA	7q32.2	A20489 A23957
Resveratrol	Investigational	NRG1	3084	downregulated	resveratrol results in decreased expression of NRG1 mRNA	8p12	A22498
Resveratrol	Investigational	NT5M	56953	upregulated	resveratrol results in increased expression of NT5M mRNA	17p11.2	A23845
Resveratrol	Investigational	NTRK3	4916	downregulated	resveratrol results in decreased expression of NTRK3 mRNA	15q25.3	A23852
Resveratrol	Investigational	OASL	8638	upregulated	resveratrol results in increased expression of OASL mRNA	12q24.31	A23852
Resveratrol	Investigational	OCLN	100506658	downregulated	resveratrol results in decreased expression of OCLN mRNA	5q13.2	A21819
Resveratrol	Investigational	ODC1	4953	downregulated	resveratrol results in decreased expression of ODC1 mRNA	2p25.1	A23995
Resveratrol	Investigational	OGG1	4968	upregulated	resveratrol results in increased expression of OGG1 mRNA	3p25.3	A22549

Displaying entries 65451 - 65475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability